Efektifitas dan keamanan terapi pseudotumor yang rekuren atau refrakter terhadap kortikosteroid sistemik
Abstract
Keywords
Full Text:
PDFReferences
Staff AAO. Pathology and Intraocular Tumor. Basic and Clinical Science Course Section 4. San Francisco: American Academy of Ophthalmology; 2009-2010. p.230-2.
Staff AAO. Orbit, Eyelid, and Lacrimal System. Basic and Clinical Science Course Section 7. San Francisco: American Academy of Ophthalmology; 2009-2010. p.69-71.
Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003 Apr; 121(4): 491-9.
Wilson MW, Galindo-Rodriquez C. Chemotherapy for adult tumors. In: Karcioglu ZA, MD (Ed). Orbital Tumor, Diagnosis and Treatment. New York: Springer; 2005. p.423.
Gausas RE, Cockerham KP, Tamhankar M. Non-spesific orbital inflammation. In: Singh AD, Damato BE, Pe’er J, Murphree AL, Perry JD. Clinical Ophthalmic Oncology. Philadelphia: Elsevier; 2007. p. 528-32.
Mendenhall WM, Lessner AM. Orbital pseudotumor. Am J Clin Oncol. 2010 Jun; 33(3):304-6.
Kennerdell JS, Dresner SC. The Nonspecific orbital inflammation. Surv Ophthalmol 1984; 29:93-103.
Chirapapaisan N, Chuenkongkaew W, Pornpanich K, et al. Orbital pseudotumor: clinical features and outcomes. Asian Pac J Allergy Immunol. 2007; 25:215–8.
Mombaerts I, Schlingemann RO, Goldschmeding R, Koornneef L. Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology 1996;103: 521–8.
Harris GJ. Idiopathic orbital inflammation: a pathogenetic construct and treatment strategy. Ophthal Plast Reconstr Surg 2006; 22:79–86.
Brannan PA. A review of sclerosing idiopathic orbital inflammation. Curr Opin Ophthalmol. 2007 Sep;18(5):402-4.
Gordon LK. Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye 2006; 20: 1196-1206
Jacobs D, Galetta S. Diagnosis and management of orbital pseudotumor. Current Opinion in Ophthalmology 2002; 13:347–51
Espinoza GM. Orbital inflammatory pseudotumors: etiology, differential diagnosis, and management. Curr Rheumatol Rep. 2010 Dec;12(6):443-7.
Mohammad Ael-N. Intralesional steroid injection for management of acute idiopathic dacryoadenitis: a preliminary result. Ophthal Plast Reconstr Surg. 2005; 21(2):138-141
Matthiesen C, Bogardus C Jr, Thompson JS, Farris B, Hildebrand L, Wikes B, et al. The Efficacy of radiotherapy in the treatment of orbital pseudomotor. Int J radiat Oncol Biol Phys. 2011 Apr 1:79(5): 1496-502
Skaat A, Rosen N, Rosner M, Schiby G, Simon GJ. Triamcinolone acetonide injection for persistent atypical idiopathic orbital inflammation. Orbit. 2009;28(6):401-3.
Oxford Centre for Evidence-based Medicine - Levels of Evidence (March 2009). Available at http://www.cebm.net/index.aspx?o=1025
Lanciano R, Fowble B, Sergott RC, et al. The results of radiotherapy for orbital pseudotumor. Int J Radiat Oncol Biol Phys 1990;18:407–11.
Barthold HJ 2nd, Harvey A, Markoe AM, et al. Treatment of orbital pseudotumors and lymphoma. Am J Clin Oncol 1986; 9:527–32.
Austin-Seymour MM, Donaldson SS, Egbert PR, et al. Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys 1985;11:371–9.
Sergott RC, Glaser JS, Charyulu K. Radiotherapy for idiopathic inflammatory orbital pseudotumor. Indications and results. Arch Ophthalmol 1981;99:853–6.
Donaldson SS, McDougall IR, Egbert PR, et al. Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy. Int J Radiat Oncol Biol Phys 1980;6: 79–86.
Leibovitch I, Prabhakaran VC, Davis G, Selva D. Intraorbital injection of triamcinolone acetonide in patients with idiopathic orbital inflammation. Arch Ophthalmol. 2007 Dec;125(12):1647-51.
Priya Y, Nithiyanandam S, Reddy MS. Role of anti metabolites in recalcitrant idiopathic orbital inflammatory syndrome. Oman J Ophthalmol 2011; 4: 21-4.
Smith JR, Rosenbaum JT. A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol. 2001 Oct; 85(10):1220-4.
Zacharopoulos IP, Papadaki T, Manor RS, Briscoe D. Treatment of idiopathic orbital inflammatory disease presentation with cyclosporine-A : a case presentation, Samin Ophthamol. 2009 Nov-Dec;24(6): 260-1
Hatton MP, Rubin PA, Foster CS. Successful Treatment of Idiopathic Orbital Inflammation with mycophenolate Mofetil. AM J Ophthalmol. 2005 Nov; 140(5):916-8
Schafranski MD. Idiopathic orbital inflammatory disease successfully treated with rituximab. Clin Rheumatol 2009 28:225–6.
Kurz PA, Suhler EB, Choi D, Rosenbaum JT. Rituximab for treatment of ocular inflammatory disease: a series of four cases. Br J Ophthalmol. 2009 Apr; 93(4):546-8.
Osborne SF, Sims JL, Rosser PM. Short-term use of infliximab in a case of recalcitrant idiopathic orbital inflammatory disease. Clin Experiment Ophthalmol. 2009 Dec; 37(9):897-900.
Prendiville C, O’Doherty M, Moriarty P, et al. The use of infliximab in ocular inflammation. Br J Ophthalmol 2008; 92:823–5.
Gamity JA, coleman AW, Mateson EL, Eggenberger ER, Waitzman DM. Treatment of Recalcitrant Idiopathic Orbital (Chronic Orbital Inflammation myositis) with infliximab. AM J Ophthamol. 2004 Dec;138(6):925-30
Wilson MW, Shergy WJ, Haik BG. Infliximab in the treatment of recalcitrant idiopathic orbital inflammation. Ophthal Plast Reconstr Surg. 2004 Sep;20(5):381-3.
Sahlin S, Lignell B, Williams M, Dastmalchi M, Orrego A. Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab. Acta Ophthalmol. 2009: 87: 906-8.
DOI: https://doi.org/10.26418/jurkeswa.v1i1.42978
Refbacks
- There are currently no refbacks.
Jurnal Kesehatan Khatulistiwa is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.